HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tommy Fu Selected Research

Bortezomib (Velcade)

10/2013Single-agent lenalidomide in patients with mantle-cell lymphoma who relapsed or progressed after or were refractory to bortezomib: phase II MCL-001 (EMERGE) study.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tommy Fu Research Topics

Disease

3Mantle-Cell Lymphoma (Lymphoma, Mantle Cell)
10/2017 - 10/2013
3Myelodysplastic Syndromes (Myelodysplastic Syndrome)
11/2014 - 10/2011
2Diffuse Large B-Cell Lymphoma (Lymphoma, Large Cell, Diffuse)
01/2018 - 12/2017
2Multiple Myeloma
01/2010 - 07/2009
1Neoplasms (Cancer)
11/2023
1Stomach Neoplasms (Stomach Cancer)
11/2023
1Small Cell Lung Carcinoma (Small Cell Lung Cancer)
11/2023
1Lymphoma (Lymphomas)
12/2017
1Follicular Lymphoma (Lymphoma, Small Cleaved Cell, Follicular)
02/2017
1Disease Progression
10/2013
1Venous Thromboembolism
01/2010
1Thromboembolism
01/2010
1Chromosome Aberrations (Chromosome Abnormalities)
07/2009

Drug/Important Bio-Agent (IBA)

7Lenalidomide (CC 5013)FDA Link
10/2017 - 07/2009
3Biomarkers (Surrogate Marker)IBA
01/2018 - 02/2017
2Dexamethasone (Maxidex)FDA LinkGeneric
01/2010 - 07/2009
1pelcitoclaxIBA
11/2023
1CaspasesIBA
11/2023
1MDS 004IBA
11/2014
1Proteins (Proteins, Gene)FDA Link
06/2014
1Bortezomib (Velcade)FDA Link
10/2013

Therapy/Procedure

4Therapeutics
01/2018 - 07/2009
1Stem Cell Transplantation
10/2013